

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.33696693 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.33696693 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.33696693 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.33696693 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.33696693 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.33696693 |
| 7 | response to peptidoglycan (GO:0032494) | 4.85084866 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.73754996 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 4.67711050 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.66313615 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 4.27471120 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.23977207 |
| 13 | glycolipid catabolic process (GO:0019377) | 4.19211676 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06872847 |
| 15 | detection of other organism (GO:0098543) | 3.96700377 |
| 16 | amino sugar catabolic process (GO:0046348) | 3.90672709 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.89358576 |
| 18 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.75782400 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71577180 |
| 20 | ceramide catabolic process (GO:0046514) | 3.67694145 |
| 21 | apoptotic cell clearance (GO:0043277) | 3.61387730 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.58334998 |
| 23 | detection of bacterium (GO:0016045) | 3.55405606 |
| 24 | mannose metabolic process (GO:0006013) | 3.54209636 |
| 25 | sodium ion export (GO:0071436) | 3.53632300 |
| 26 | regulation of mast cell degranulation (GO:0043304) | 3.51470368 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.47830729 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.40801281 |
| 29 | response to host immune response (GO:0052572) | 3.40801281 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.32493972 |
| 31 | response to thyroid hormone (GO:0097066) | 3.31589676 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.31219262 |
| 33 | positive regulation of macrophage cytokine production (GO:0060907) | 3.30110181 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.29485817 |
| 35 | positive regulation of mast cell degranulation (GO:0043306) | 3.29130924 |
| 36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29130924 |
| 37 | regulation of mononuclear cell migration (GO:0071675) | 3.25006932 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24208611 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.23795422 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.20159745 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.19843035 |
| 42 | response to host (GO:0075136) | 3.18507938 |
| 43 | response to host defenses (GO:0052200) | 3.18507938 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18507938 |
| 45 | regulation of cholesterol storage (GO:0010885) | 3.17249231 |
| 46 | N-acetylneuraminate metabolic process (GO:0006054) | 3.16328109 |
| 47 | cellular extravasation (GO:0045123) | 3.14503685 |
| 48 | response to muramyl dipeptide (GO:0032495) | 3.13903294 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.11212611 |
| 50 | regulation of ARF protein signal transduction (GO:0032012) | 3.10041798 |
| 51 | granulocyte activation (GO:0036230) | 3.08466829 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07906440 |
| 53 | protein localization to endosome (GO:0036010) | 3.07851428 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.07808064 |
| 55 | microglial cell activation (GO:0001774) | 3.05846139 |
| 56 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.05694748 |
| 57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.01978253 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.00735619 |
| 59 | cellular potassium ion homeostasis (GO:0030007) | 2.97426232 |
| 60 | positive regulation of interferon-alpha production (GO:0032727) | 2.93888210 |
| 61 | membrane lipid catabolic process (GO:0046466) | 2.90570569 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89749821 |
| 63 | regulation of mast cell activation (GO:0033003) | 2.89575423 |
| 64 | respiratory burst (GO:0045730) | 2.88664492 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 2.87522835 |
| 66 | locomotory exploration behavior (GO:0035641) | 2.87410418 |
| 67 | alanine transport (GO:0032328) | 2.87238364 |
| 68 | sphingolipid catabolic process (GO:0030149) | 2.85935911 |
| 69 | germinal center formation (GO:0002467) | 2.84048664 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82273896 |
| 71 | negative regulation of cell killing (GO:0031342) | 2.80270205 |
| 72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80270205 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79170943 |
| 74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78870227 |
| 75 | stress fiber assembly (GO:0043149) | 2.78511864 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77967147 |
| 77 | neutrophil activation (GO:0042119) | 2.77766087 |
| 78 | regulation of macrophage cytokine production (GO:0010935) | 2.77114872 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 2.76244546 |
| 80 | L-amino acid import (GO:0043092) | 2.74389436 |
| 81 | regulation of early endosome to late endosome transport (GO:2000641) | 2.74064213 |
| 82 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.73275303 |
| 83 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72873619 |
| 84 | proline transport (GO:0015824) | 2.72361526 |
| 85 | macrophage activation (GO:0042116) | 2.70931567 |
| 86 | regulation of monocyte chemotaxis (GO:0090025) | 2.70001694 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 2.66836647 |
| 88 | positive regulation of cholesterol efflux (GO:0010875) | 2.65285905 |
| 89 | regulation of superoxide anion generation (GO:0032928) | 2.64570693 |
| 90 | regulation of macrophage chemotaxis (GO:0010758) | 2.63929912 |
| 91 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.63798923 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.61699133 |
| 93 | peptide catabolic process (GO:0043171) | 2.61687629 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 2.61556107 |
| 95 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60541238 |
| 96 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.60528085 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.60013170 |
| 98 | regulation of T cell tolerance induction (GO:0002664) | 2.59622453 |
| 99 | regulation of podosome assembly (GO:0071801) | 2.59463659 |
| 100 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59443927 |
| 101 | positive regulation of regulated secretory pathway (GO:1903307) | 2.58721966 |
| 102 | clathrin coat assembly (GO:0048268) | 2.58603588 |
| 103 | keratan sulfate catabolic process (GO:0042340) | 2.58324296 |
| 104 | positive regulation of type 2 immune response (GO:0002830) | 2.55446810 |
| 105 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.54998669 |
| 106 | plasma membrane repair (GO:0001778) | 2.54795471 |
| 107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.54077883 |
| 108 | negative regulation of interleukin-17 production (GO:0032700) | 2.51368196 |
| 109 | cortical actin cytoskeleton organization (GO:0030866) | 2.50835270 |
| 110 | response to laminar fluid shear stress (GO:0034616) | 2.50069357 |
| 111 | type I interferon signaling pathway (GO:0060337) | 2.49052128 |
| 112 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48482048 |
| 113 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.48482048 |
| 114 | activation of protein kinase A activity (GO:0034199) | 2.46273672 |
| 115 | I-kappaB phosphorylation (GO:0007252) | 2.46138739 |
| 116 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43575404 |
| 117 | macroautophagy (GO:0016236) | 2.43502869 |
| 118 | neutrophil activation involved in immune response (GO:0002283) | 2.43366879 |
| 119 | lipoprotein transport (GO:0042953) | 2.43349130 |
| 120 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.41581776 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 2.40689985 |
| 122 | potassium ion import (GO:0010107) | 2.40583481 |
| 123 | myeloid cell activation involved in immune response (GO:0002275) | 2.38970026 |
| 124 | regulation of ARF GTPase activity (GO:0032312) | 2.37232339 |
| 125 | response to lipoprotein particle (GO:0055094) | 2.37134697 |
| 126 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37040656 |
| 127 | positive regulation of leukocyte degranulation (GO:0043302) | 2.36904656 |
| 128 | cell adhesion mediated by integrin (GO:0033627) | 2.35262818 |
| 129 | regulation of regulated secretory pathway (GO:1903305) | 2.34997191 |
| 130 | phagosome maturation (GO:0090382) | 2.34968577 |
| 131 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.33609548 |
| 132 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.33545196 |
| 133 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.33253171 |
| 134 | amino acid import (GO:0043090) | 2.32773820 |
| 135 | positive regulation of bone resorption (GO:0045780) | 2.32525935 |
| 136 | positive regulation of bone remodeling (GO:0046852) | 2.32525935 |
| 137 | barbed-end actin filament capping (GO:0051016) | 2.30517427 |
| 138 | receptor catabolic process (GO:0032801) | 2.29686920 |
| 139 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.28446296 |
| 140 | immunoglobulin mediated immune response (GO:0016064) | 2.28207028 |
| 141 | cerebellar Purkinje cell layer development (GO:0021680) | 2.26168507 |
| 142 | positive regulation of mast cell activation (GO:0033005) | 2.24502555 |
| 143 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24391399 |
| 144 | layer formation in cerebral cortex (GO:0021819) | 2.24163415 |
| 145 | positive regulation of p38MAPK cascade (GO:1900745) | 2.24015546 |
| 146 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.20346431 |
| 147 | neuromuscular process controlling balance (GO:0050885) | 2.19559322 |
| 148 | phagocytosis (GO:0006909) | 2.19224863 |
| 149 | adenosine receptor signaling pathway (GO:0001973) | 2.18293988 |
| 150 | synaptic vesicle exocytosis (GO:0016079) | 2.17138179 |
| 151 | cortical cytoskeleton organization (GO:0030865) | 2.16429630 |
| 152 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.14058907 |
| 153 | positive regulation of phagocytosis (GO:0050766) | 2.10691995 |
| 154 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.09778272 |
| 155 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.07844461 |
| 156 | cell communication by electrical coupling (GO:0010644) | 2.07509084 |
| 157 | regulation of beta-amyloid formation (GO:1902003) | 2.06283854 |
| 158 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.05947877 |
| 159 | pinocytosis (GO:0006907) | 2.05841918 |
| 160 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.05223594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19104216 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78283997 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.63637818 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51524379 |
| 5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49680899 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37226404 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27483062 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17305988 |
| 9 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15013328 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94532709 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90219053 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89677708 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89263315 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85716993 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85632176 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84652419 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82290523 |
| 18 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80875018 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.80451251 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80350986 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79329854 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74684604 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72319559 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72025389 |
| 25 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.70142603 |
| 26 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67403074 |
| 27 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65784665 |
| 28 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65723108 |
| 29 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.65701963 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64982090 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62257052 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58830950 |
| 33 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58171478 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57504177 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56773284 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.56541731 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55702004 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.55318102 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50991759 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.49607612 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47662091 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47549636 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.47514777 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45567769 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44958347 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44714921 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44144403 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43563134 |
| 49 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42702735 |
| 50 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.42142137 |
| 51 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39896386 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38786451 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38718543 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37836688 |
| 55 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37808442 |
| 56 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37363237 |
| 57 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35364052 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34565845 |
| 59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32286572 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30854748 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30806406 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30772543 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29061226 |
| 64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28844219 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28536623 |
| 66 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.27198124 |
| 67 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25901094 |
| 68 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.24810748 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23259716 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22879107 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21808203 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21761756 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21465873 |
| 74 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20523876 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19341723 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18834731 |
| 77 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18087648 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17833115 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16660317 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15780277 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14951062 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14666611 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14535801 |
| 84 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14165507 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14088888 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13566732 |
| 87 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12430898 |
| 88 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11509318 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11137587 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11032961 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10400604 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10141024 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09769077 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08724916 |
| 95 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07050906 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05599299 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05388177 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05126003 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03231214 |
| 100 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03203597 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02613828 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02056259 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98890903 |
| 104 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98630791 |
| 105 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98630791 |
| 106 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98431150 |
| 107 | MAF_26560356_Chip-Seq_TH2_Human | 0.98319301 |
| 108 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98294617 |
| 109 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.96242887 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96046768 |
| 111 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95355148 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 0.95327268 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93870295 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93521456 |
| 115 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93011157 |
| 116 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92653280 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92651625 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92603427 |
| 119 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92376832 |
| 120 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91861944 |
| 121 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91811947 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91806404 |
| 123 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91340226 |
| 124 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90532889 |
| 125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90532889 |
| 126 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89302964 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89196833 |
| 128 | MYC_22102868_ChIP-Seq_BL_Human | 0.89084473 |
| 129 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.87888547 |
| 130 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87408083 |
| 131 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87156435 |
| 132 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.87099193 |
| 133 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87057239 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87027564 |
| 135 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.86790005 |
| 136 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86583866 |
| 137 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86399272 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85095261 |
| 139 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84431052 |
| 140 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84311292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.23060519 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.09103157 |
| 3 | MP0003303_peritoneal_inflammation | 3.87253971 |
| 4 | MP0003724_increased_susceptibility_to | 3.35038527 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.34857807 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.97908795 |
| 7 | MP0009840_abnormal_foam_cell | 2.73200383 |
| 8 | MP0000604_amyloidosis | 2.68235827 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.67113025 |
| 10 | MP0004858_abnormal_nervous_system | 2.63644251 |
| 11 | MP0004510_myositis | 2.63084766 |
| 12 | MP0009785_altered_susceptibility_to | 2.38034512 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.36688553 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.32067054 |
| 15 | MP0006082_CNS_inflammation | 2.31038627 |
| 16 | MP0003075_altered_response_to | 2.21402265 |
| 17 | * MP0003690_abnormal_glial_cell | 2.19482898 |
| 18 | MP0005671_abnormal_response_to | 2.17431779 |
| 19 | MP0005451_abnormal_body_composition | 2.10865013 |
| 20 | MP0004130_abnormal_muscle_cell | 2.10002835 |
| 21 | MP0003329_amyloid_beta_deposits | 1.98351418 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.95789475 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.95090896 |
| 24 | MP0008260_abnormal_autophagy | 1.89507934 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.86133907 |
| 26 | MP0001958_emphysema | 1.81769767 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.76217337 |
| 28 | MP0003436_decreased_susceptibility_to | 1.74448461 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.72035663 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.70465219 |
| 31 | * MP0002419_abnormal_innate_immunity | 1.68153266 |
| 32 | MP0003828_pulmonary_edema | 1.67079423 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.58937969 |
| 34 | MP0009764_decreased_sensitivity_to | 1.58344415 |
| 35 | MP0001853_heart_inflammation | 1.55077500 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.54137190 |
| 37 | MP0002090_abnormal_vision | 1.53489036 |
| 38 | MP0000858_altered_metastatic_potential | 1.50933081 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.48226054 |
| 40 | MP0008004_abnormal_stomach_pH | 1.43813424 |
| 41 | MP0005166_decreased_susceptibility_to | 1.41152218 |
| 42 | MP0003045_fibrosis | 1.39955470 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.39530214 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.37412652 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.34904051 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.31569293 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.31431907 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.31090244 |
| 49 | * MP0003635_abnormal_synaptic_transmissio | 1.30096593 |
| 50 | MP0006054_spinal_hemorrhage | 1.29378958 |
| 51 | * MP0003634_abnormal_glial_cell | 1.28545214 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.26911160 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.26777265 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.26777265 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.26537118 |
| 56 | MP0005310_abnormal_salivary_gland | 1.23547006 |
| 57 | MP0000343_altered_response_to | 1.22684649 |
| 58 | * MP0002064_seizures | 1.22676353 |
| 59 | MP0009278_abnormal_bone_marrow | 1.19984257 |
| 60 | MP0004947_skin_inflammation | 1.19914581 |
| 61 | MP0003091_abnormal_cell_migration | 1.19760007 |
| 62 | MP0001790_abnormal_immune_system | 1.16409131 |
| 63 | MP0005387_immune_system_phenotype | 1.16409131 |
| 64 | MP0009046_muscle_twitch | 1.16046823 |
| 65 | MP0004883_abnormal_blood_vessel | 1.14451102 |
| 66 | MP0003448_altered_tumor_morphology | 1.13933349 |
| 67 | MP0010307_abnormal_tumor_latency | 1.13880310 |
| 68 | * MP0003633_abnormal_nervous_system | 1.07181989 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.06950668 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 1.06267126 |
| 71 | * MP0000716_abnormal_immune_system | 1.04944136 |
| 72 | * MP0002452_abnormal_antigen_presenting | 1.04584134 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.04105157 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.03613875 |
| 75 | MP0001851_eye_inflammation | 1.01203280 |
| 76 | MP0005025_abnormal_response_to | 0.98634599 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.97543104 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.95066658 |
| 79 | * MP0000920_abnormal_myelination | 0.93472048 |
| 80 | MP0000751_myopathy | 0.92378052 |
| 81 | MP0005165_increased_susceptibility_to | 0.92185028 |
| 82 | MP0005390_skeleton_phenotype | 0.91867609 |
| 83 | MP0002254_reproductive_system_inflammat | 0.91271681 |
| 84 | MP0005670_abnormal_white_adipose | 0.90723235 |
| 85 | MP0002063_abnormal_learning/memory/cond | 0.88526025 |
| 86 | MP0004270_analgesia | 0.86373441 |
| 87 | MP0001849_ear_inflammation | 0.84279567 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.84132622 |
| 89 | MP0009763_increased_sensitivity_to | 0.83313531 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.81747951 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.81234200 |
| 92 | MP0002398_abnormal_bone_marrow | 0.80666236 |
| 93 | MP0002723_abnormal_immune_serum | 0.80150437 |
| 94 | MP0005365_abnormal_bile_salt | 0.79221635 |
| 95 | MP0000685_abnormal_immune_system | 0.78579585 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.78184890 |
| 97 | * MP0002429_abnormal_blood_cell | 0.78067892 |
| 98 | * MP0001819_abnormal_immune_cell | 0.75897074 |
| 99 | MP0001542_abnormal_bone_strength | 0.75780317 |
| 100 | * MP0001845_abnormal_inflammatory_respons | 0.75491728 |
| 101 | * MP0000689_abnormal_spleen_morphology | 0.75429745 |
| 102 | MP0003283_abnormal_digestive_organ | 0.75047286 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.74857059 |
| 104 | MP0010329_abnormal_lipoprotein_level | 0.74632263 |
| 105 | * MP0002420_abnormal_adaptive_immunity | 0.73867159 |
| 106 | MP0008469_abnormal_protein_level | 0.73490525 |
| 107 | MP0009745_abnormal_behavioral_response | 0.72481499 |
| 108 | MP0001800_abnormal_humoral_immune | 0.70735691 |
| 109 | * MP0003631_nervous_system_phenotype | 0.70039451 |
| 110 | * MP0004811_abnormal_neuron_physiology | 0.69931612 |
| 111 | * MP0002722_abnormal_immune_system | 0.68005923 |
| 112 | MP0002148_abnormal_hypersensitivity_rea | 0.67639510 |
| 113 | MP0005535_abnormal_body_temperature | 0.67087908 |
| 114 | MP0001663_abnormal_digestive_system | 0.66574271 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.66414542 |
| 116 | MP0000371_diluted_coat_color | 0.66238139 |
| 117 | MP0003279_aneurysm | 0.65243793 |
| 118 | MP0002168_other_aberrant_phenotype | 0.64995962 |
| 119 | * MP0008569_lethality_at_weaning | 0.64514045 |
| 120 | MP0008874_decreased_physiological_sensi | 0.63886054 |
| 121 | MP0000249_abnormal_blood_vessel | 0.63412296 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.63305932 |
| 123 | MP0002971_abnormal_brown_adipose | 0.62563097 |
| 124 | MP0002405_respiratory_system_inflammati | 0.62153128 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.62109697 |
| 126 | MP0005023_abnormal_wound_healing | 0.62102546 |
| 127 | MP0000733_abnormal_muscle_development | 0.60769140 |
| 128 | * MP0001756_abnormal_urination | 0.59429671 |
| 129 | MP0005275_abnormal_skin_tensile | 0.59370366 |
| 130 | MP0005164_abnormal_response_to | 0.58117673 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.57251577 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.56541287 |
| 133 | MP0003795_abnormal_bone_structure | 0.56508202 |
| 134 | * MP0003632_abnormal_nervous_system | 0.56455542 |
| 135 | MP0001915_intracranial_hemorrhage | 0.56056972 |
| 136 | MP0001440_abnormal_grooming_behavior | 0.56034265 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.55329742 |
| 138 | MP0002933_joint_inflammation | 0.52562624 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.51578027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysostosis multiplex (HP:0000943) | 4.95589288 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.91694852 |
| 3 | * Increased cerebral lipofuscin (HP:0011813) | 4.91694852 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.41413934 |
| 5 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.26144706 |
| 6 | Mucopolysacchariduria (HP:0008155) | 4.26144706 |
| 7 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.08814368 |
| 8 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.08814368 |
| 9 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.08814368 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.65020740 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.53871711 |
| 12 | Axonal loss (HP:0003447) | 3.48430136 |
| 13 | Disinhibition (HP:0000734) | 3.48067617 |
| 14 | Orchitis (HP:0100796) | 3.38700561 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.36876326 |
| 16 | Mutism (HP:0002300) | 3.30690724 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.27601529 |
| 18 | Myositis (HP:0100614) | 3.25990962 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.21984163 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.16031100 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.11487648 |
| 22 | Optic neuritis (HP:0100653) | 3.11487648 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 3.06889743 |
| 24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.02643168 |
| 25 | Nuclear cataract (HP:0100018) | 3.02071033 |
| 26 | Apathy (HP:0000741) | 3.00004058 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.96446183 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.94230993 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.91310088 |
| 30 | Diminished motivation (HP:0000745) | 2.90658226 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.79643811 |
| 32 | Purpura (HP:0000979) | 2.79107576 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.76421788 |
| 34 | * Abnormality of liposaccharide metabolism (HP:0010968) | 2.74323204 |
| 35 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74323204 |
| 36 | * Abnormality of glycolipid metabolism (HP:0010969) | 2.74323204 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.60890572 |
| 38 | Obstructive lung disease (HP:0006536) | 2.60669299 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60669299 |
| 40 | * Neuronal loss in central nervous system (HP:0002529) | 2.59693829 |
| 41 | Stomatitis (HP:0010280) | 2.59079605 |
| 42 | Upper limb amyotrophy (HP:0009129) | 2.50950303 |
| 43 | Distal upper limb amyotrophy (HP:0007149) | 2.50950303 |
| 44 | J-shaped sella turcica (HP:0002680) | 2.47848424 |
| 45 | Glomerulonephritis (HP:0000099) | 2.47736788 |
| 46 | Myocardial infarction (HP:0001658) | 2.43500874 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.42597787 |
| 48 | * Loss of speech (HP:0002371) | 2.41432227 |
| 49 | Hand muscle atrophy (HP:0009130) | 2.40847749 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.35682435 |
| 51 | Retinal atrophy (HP:0001105) | 2.34953490 |
| 52 | Papilledema (HP:0001085) | 2.28696726 |
| 53 | Inappropriate behavior (HP:0000719) | 2.28345134 |
| 54 | Hematochezia (HP:0002573) | 2.25542159 |
| 55 | Increased serum ferritin (HP:0003281) | 2.24072895 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.24006604 |
| 57 | Frequent falls (HP:0002359) | 2.22278273 |
| 58 | Visual hallucinations (HP:0002367) | 2.21843929 |
| 59 | Striae distensae (HP:0001065) | 2.16095826 |
| 60 | Personality changes (HP:0000751) | 2.15878669 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.14114035 |
| 62 | Agnosia (HP:0010524) | 2.13703629 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.12695253 |
| 64 | Urticaria (HP:0001025) | 2.10795718 |
| 65 | Rapidly progressive (HP:0003678) | 2.10377701 |
| 66 | Action tremor (HP:0002345) | 2.08877363 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.08755682 |
| 68 | Diplopia (HP:0000651) | 2.08755682 |
| 69 | Gingivitis (HP:0000230) | 2.06120724 |
| 70 | Arterial tortuosity (HP:0005116) | 2.04728704 |
| 71 | Thoracic kyphosis (HP:0002942) | 1.99098078 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 1.99085208 |
| 73 | Upper motor neuron abnormality (HP:0002127) | 1.99026583 |
| 74 | Abnormality of the lumbar spine (HP:0100712) | 1.98629248 |
| 75 | * Hepatosplenomegaly (HP:0001433) | 1.96003104 |
| 76 | Dementia (HP:0000726) | 1.94916006 |
| 77 | Hemoptysis (HP:0002105) | 1.94392139 |
| 78 | Ovoid vertebral bodies (HP:0003300) | 1.94363191 |
| 79 | Postural instability (HP:0002172) | 1.94187820 |
| 80 | Complement deficiency (HP:0004431) | 1.92724365 |
| 81 | Meningitis (HP:0001287) | 1.92693116 |
| 82 | Cervical subluxation (HP:0003308) | 1.92643320 |
| 83 | Petechiae (HP:0000967) | 1.91959830 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91945852 |
| 85 | Nephritis (HP:0000123) | 1.89581254 |
| 86 | Bone pain (HP:0002653) | 1.89123188 |
| 87 | Achilles tendon contracture (HP:0001771) | 1.88660022 |
| 88 | Vascular tortuosity (HP:0004948) | 1.86471279 |
| 89 | Keratoconjunctivitis (HP:0001096) | 1.85869995 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 1.83582886 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 1.82653238 |
| 92 | Vasculitis (HP:0002633) | 1.82309797 |
| 93 | Hemiplegia (HP:0002301) | 1.78477835 |
| 94 | Abnormal eating behavior (HP:0100738) | 1.77426746 |
| 95 | Memory impairment (HP:0002354) | 1.77353603 |
| 96 | Myokymia (HP:0002411) | 1.76842551 |
| 97 | Basal ganglia calcification (HP:0002135) | 1.76063812 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.75261389 |
| 99 | Malnutrition (HP:0004395) | 1.74419062 |
| 100 | Long toe (HP:0010511) | 1.73536707 |
| 101 | Focal seizures (HP:0007359) | 1.72735199 |
| 102 | Abnormality of complement system (HP:0005339) | 1.72586451 |
| 103 | Restrictive lung disease (HP:0002091) | 1.72575476 |
| 104 | Abnormality of the Achilles tendon (HP:0005109) | 1.72242697 |
| 105 | Turricephaly (HP:0000262) | 1.71877819 |
| 106 | Polygenic inheritance (HP:0010982) | 1.70150872 |
| 107 | Recurrent viral infections (HP:0004429) | 1.69896455 |
| 108 | Hyperacusis (HP:0010780) | 1.69732613 |
| 109 | Xanthomatosis (HP:0000991) | 1.69369974 |
| 110 | Increased IgE level (HP:0003212) | 1.69228928 |
| 111 | Cellulitis (HP:0100658) | 1.68811211 |
| 112 | T lymphocytopenia (HP:0005403) | 1.68012952 |
| 113 | Aortic aneurysm (HP:0004942) | 1.66461736 |
| 114 | Deformed sella turcica (HP:0002681) | 1.65930508 |
| 115 | Gingival bleeding (HP:0000225) | 1.65177695 |
| 116 | Arterial thrombosis (HP:0004420) | 1.65134264 |
| 117 | Progressive visual loss (HP:0000529) | 1.65084710 |
| 118 | Cardiomegaly (HP:0001640) | 1.63960299 |
| 119 | Mitral valve prolapse (HP:0001634) | 1.63793215 |
| 120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.63582519 |
| 121 | Gastrointestinal infarctions (HP:0005244) | 1.63533747 |
| 122 | Spondylolisthesis (HP:0003302) | 1.62926362 |
| 123 | Depression (HP:0000716) | 1.62696991 |
| 124 | Recurrent cutaneous fungal infections (HP:0011370) | 1.62232435 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.62232435 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.62185682 |
| 127 | Osteomyelitis (HP:0002754) | 1.62043200 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.61993941 |
| 129 | Acrocyanosis (HP:0001063) | 1.61584040 |
| 130 | Neurodegeneration (HP:0002180) | 1.61539804 |
| 131 | Dilatation of the ascending aorta (HP:0005111) | 1.60258818 |
| 132 | Abnormality of the thoracic spine (HP:0100711) | 1.60132705 |
| 133 | Colitis (HP:0002583) | 1.58924982 |
| 134 | Amyloidosis (HP:0011034) | 1.58703211 |
| 135 | Bundle branch block (HP:0011710) | 1.58457352 |
| 136 | Pathologic fracture (HP:0002756) | 1.57293170 |
| 137 | Conjunctival telangiectasia (HP:0000524) | 1.56242535 |
| 138 | * Increased CSF protein (HP:0002922) | 1.56097178 |
| 139 | Aneurysm (HP:0002617) | 1.55070158 |
| 140 | Recurrent skin infections (HP:0001581) | 1.54921909 |
| 141 | Sensorimotor neuropathy (HP:0007141) | 1.54638014 |
| 142 | Shallow orbits (HP:0000586) | 1.54423461 |
| 143 | Coarse hair (HP:0002208) | 1.54394979 |
| 144 | Macroorchidism (HP:0000053) | 1.54209802 |
| 145 | Protuberant abdomen (HP:0001538) | 1.53485989 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.53478862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.24904770 |
| 2 | IRAK3 | 3.05431016 |
| 3 | RIPK4 | 3.02776060 |
| 4 | PRPF4B | 2.97010656 |
| 5 | MAP3K9 | 2.76586650 |
| 6 | ERN1 | 2.68469513 |
| 7 | PKN2 | 2.54447039 |
| 8 | RIPK1 | 2.51457804 |
| 9 | KSR2 | 2.32670557 |
| 10 | MAP3K14 | 2.30781791 |
| 11 | CAMKK1 | 2.18941651 |
| 12 | SCYL2 | 2.10555492 |
| 13 | MAP3K3 | 2.03493662 |
| 14 | TTN | 2.00003922 |
| 15 | GRK7 | 1.98145261 |
| 16 | DAPK2 | 1.94194647 |
| 17 | CAMK1D | 1.82812909 |
| 18 | TAOK2 | 1.79964292 |
| 19 | IRAK4 | 1.78970467 |
| 20 | MAP3K11 | 1.78801393 |
| 21 | PAK6 | 1.76227863 |
| 22 | CAMK1G | 1.71635651 |
| 23 | NTRK1 | 1.65026694 |
| 24 | NME2 | 1.63754495 |
| 25 | TGFBR2 | 1.58517198 |
| 26 | FES | 1.57969364 |
| 27 | PTK6 | 1.56315201 |
| 28 | CAMKK2 | 1.55661800 |
| 29 | KIT | 1.54597651 |
| 30 | PRKD3 | 1.52545650 |
| 31 | TBK1 | 1.51435647 |
| 32 | PRKCH | 1.50025888 |
| 33 | JAK1 | 1.46394283 |
| 34 | EPHB1 | 1.46173283 |
| 35 | MAP3K2 | 1.41069218 |
| 36 | TYK2 | 1.39717508 |
| 37 | JAK3 | 1.37074297 |
| 38 | MAP3K13 | 1.35048466 |
| 39 | SIK2 | 1.32962853 |
| 40 | NTRK3 | 1.32079847 |
| 41 | BLK | 1.31569441 |
| 42 | PDGFRA | 1.30081085 |
| 43 | RET | 1.23081777 |
| 44 | STK38 | 1.21581542 |
| 45 | BMX | 1.21149785 |
| 46 | ALK | 1.19475017 |
| 47 | TESK2 | 1.11417150 |
| 48 | LMTK2 | 1.10141585 |
| 49 | JAK2 | 1.07119464 |
| 50 | BMPR2 | 1.06531019 |
| 51 | IKBKE | 1.06015118 |
| 52 | PDPK1 | 1.04890310 |
| 53 | TAOK1 | 1.04042378 |
| 54 | HCK | 1.01369174 |
| 55 | LRRK2 | 0.98868622 |
| 56 | MINK1 | 0.98738690 |
| 57 | PAK4 | 0.98123808 |
| 58 | IKBKB | 0.97980259 |
| 59 | CSF1R | 0.97950384 |
| 60 | IRAK2 | 0.97124326 |
| 61 | FGR | 0.97024664 |
| 62 | TESK1 | 0.96668703 |
| 63 | PDK1 | 0.92584352 |
| 64 | LYN | 0.91313666 |
| 65 | PIM2 | 0.90681798 |
| 66 | MAP3K1 | 0.90047513 |
| 67 | SIK1 | 0.86614704 |
| 68 | DDR2 | 0.84609982 |
| 69 | SGK3 | 0.83648528 |
| 70 | TYRO3 | 0.81405358 |
| 71 | EPHA4 | 0.81106941 |
| 72 | MARK2 | 0.78768154 |
| 73 | DMPK | 0.77288684 |
| 74 | CDK5 | 0.76852501 |
| 75 | BTK | 0.74389052 |
| 76 | CSK | 0.74220339 |
| 77 | TNK2 | 0.74110194 |
| 78 | MAP4K1 | 0.73300813 |
| 79 | EEF2K | 0.73293164 |
| 80 | FYN | 0.73131727 |
| 81 | LCK | 0.72491748 |
| 82 | MAP3K5 | 0.72109722 |
| 83 | PDGFRB | 0.71701464 |
| 84 | CDK6 | 0.70385146 |
| 85 | SIK3 | 0.69256264 |
| 86 | MAPK7 | 0.68184983 |
| 87 | EPHA3 | 0.67525031 |
| 88 | PDK2 | 0.66800000 |
| 89 | MATK | 0.66307795 |
| 90 | PTK2B | 0.65678234 |
| 91 | PTK2 | 0.64838408 |
| 92 | NTRK2 | 0.63736877 |
| 93 | MAPK12 | 0.62845193 |
| 94 | STK10 | 0.62511185 |
| 95 | FGFR3 | 0.61708636 |
| 96 | IRAK1 | 0.61135337 |
| 97 | MAP2K3 | 0.60769876 |
| 98 | EGFR | 0.60724897 |
| 99 | MARK3 | 0.60343702 |
| 100 | TAOK3 | 0.59201829 |
| 101 | MOS | 0.56841634 |
| 102 | MAP3K6 | 0.56415902 |
| 103 | DAPK3 | 0.55101831 |
| 104 | RPS6KA2 | 0.54934463 |
| 105 | MAP2K1 | 0.54586460 |
| 106 | MARK1 | 0.54541253 |
| 107 | TXK | 0.54308801 |
| 108 | SYK | 0.54186523 |
| 109 | FGFR4 | 0.53453814 |
| 110 | PRKD2 | 0.53014176 |
| 111 | MAP2K4 | 0.52940700 |
| 112 | PRKD1 | 0.52244568 |
| 113 | ICK | 0.51653933 |
| 114 | RPS6KC1 | 0.50879675 |
| 115 | RPS6KL1 | 0.50879675 |
| 116 | SRC | 0.50833691 |
| 117 | MAP3K10 | 0.49610596 |
| 118 | PHKG2 | 0.49254096 |
| 119 | PHKG1 | 0.49254096 |
| 120 | ZAP70 | 0.48367535 |
| 121 | KSR1 | 0.48116438 |
| 122 | YES1 | 0.46798683 |
| 123 | DAPK1 | 0.46771985 |
| 124 | CHUK | 0.45591492 |
| 125 | ACVR1B | 0.44284230 |
| 126 | ARAF | 0.44182894 |
| 127 | ABL2 | 0.43595854 |
| 128 | MAP3K4 | 0.43540484 |
| 129 | STK11 | 0.43318867 |
| 130 | NEK9 | 0.42005979 |
| 131 | CDC42BPA | 0.41555857 |
| 132 | PAK2 | 0.40057078 |
| 133 | GRK6 | 0.39586455 |
| 134 | LATS2 | 0.38590740 |
| 135 | DYRK1B | 0.38585817 |
| 136 | CAMK4 | 0.37572560 |
| 137 | MAPK4 | 0.36377416 |
| 138 | ABL1 | 0.35364792 |
| 139 | PAK3 | 0.34568130 |
| 140 | NEK1 | 0.34556057 |
| 141 | SGK1 | 0.34393937 |
| 142 | CAMK1 | 0.34242553 |
| 143 | WNK1 | 0.34076162 |
| 144 | FER | 0.32273985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.93072145 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 2.83744327 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93824615 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 1.90974620 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.81543064 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.74477908 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70922922 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70670995 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63405778 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62426650 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62278628 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.60868805 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59268795 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.49216340 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.45659165 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43205063 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43179583 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.41740468 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40909845 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40526563 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39246688 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37536683 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33618978 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.31888959 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28347633 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27641283 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25380393 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21882490 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20074383 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19099377 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.19089994 |
| 32 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15392699 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14730602 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13146158 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.13075185 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12967264 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11632138 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10826902 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09899115 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.07393891 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04878813 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04545966 |
| 43 | Endocytosis_Homo sapiens_hsa04144 | 1.04533813 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01656310 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98070998 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 0.97630370 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.95537468 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94731017 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94411432 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94253703 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94000908 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.93683865 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93179470 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92736737 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92487423 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92166076 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91017895 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88109144 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.87787568 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87756111 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.87464004 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87272886 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87042659 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.87042217 |
| 65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85658946 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.85394710 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84368426 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84311186 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84151215 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83745116 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83005922 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82969068 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82804626 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82464178 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81964128 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81490892 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80762258 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80000469 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79242028 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79140092 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.78901364 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78853843 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78212586 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78024705 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.77931749 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.77548807 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.77447198 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77172931 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.77167120 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76844550 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.75447833 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.74901655 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74747496 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74160382 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73621888 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72885249 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.72550866 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71844844 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70904281 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.70520606 |
| 101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.70278552 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68650596 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68395416 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68171458 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67505984 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67056993 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66829677 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.65389021 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.64214780 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63960143 |
| 111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63770784 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63259112 |
| 113 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63113731 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62332416 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60960795 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60943392 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60898456 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59924348 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.59744872 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59396975 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57552756 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57457240 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56950582 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56854403 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56835879 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.55914933 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54957828 |
| 128 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54317078 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53381320 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53038136 |
| 131 | Long-term depression_Homo sapiens_hsa04730 | 0.52890455 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52670330 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48551008 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45909268 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43435793 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.37716792 |
| 137 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36546704 |
| 138 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32212131 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31550696 |

